Best of the Week
Most Popular
1. 2019 From A Fourth Turning Perspective - James_Quinn
2.Beware the Young Stocks Bear Market! - Zeal_LLC
3.Safe Havens are Surging. What this Means for Stocks 2019 - Troy_Bombardia
4.Most Popular Financial Markets Analysis of 2018 - Trump and BrExit Chaos Dominate - Nadeem_Walayat
5.January 2019 Financial Markets Analysis and Forecasts - Nadeem_Walayat
6.Silver Price Trend Analysis 2019 - Nadeem_Walayat
7.Why 90% of Traders Lose - Nadeem_Walayat
8.What to do With Your Money in a Stocks Bear Market - Stephen_McBride
9.Stock Market What to Expect in the First 3~5 Months of 2019 - Chris_Vermeulen
10.China, Global Economy has Tipped over: The Surging Dollar and the Rallying Yen - FXCOT
Last 7 days
Forex Trading Management: The Importance of Being Prepared - 19th Feb 19
Gold Stocks are Following This Historical Template - 19th Feb 19
Here’s Why The Left’s New Economic Policies Are Just Stupid - 19th Feb 19
Should We Declare Emergency for Gold? - 19th Feb 19
Why Stock Traders Must Stay Optimistically Cautious Going Forward - 19th Feb 19
The Corporate Debt Bubble Is Strikingly Similar to the Subprime Mortgage Bubble - 18th Feb 19
Stacking The Next QE On Top Of A $4 Trillion Fed Floor - 18th Feb 19
Get ready for the Stock Market Breakout Pattern Setup II - 18th Feb 19
It's Blue Skies For The Stock Market As Far As The Eye Can See - 18th Feb 19
Stock Market Correction is Due - 18th Feb 19
Iran's Death Spiral -- 40 Years And Counting - 17 Feb 19
Venezuela's Opposition Is Playing With Fire - 17 Feb 19
Fed Chairman Deceives; Precious Metals Mine Supply Threatened - 17 Feb 19
After 8 Terrific Weeks for Stocks, What’s Next? - 16th Feb 19
My Favorite Real Estate Strategies: Rent to Live, Buy to Rent - 16th Feb 19
Schumer & Sanders Want One Thing: Your Money - 16th Feb 19
What Could Happen When the Stock Markets Correct Next - 16th Feb 19
Bitcoin Your Best Opportunity Outside of Stocks - 16th Feb 19
Olympus TG-5 Tough Camera Under SEA Water Test - 16th Feb 19
"Mi Amigo" Sheffield Bomber Crash Memorial Site Fly-past on 22nd February 2019 VR360 - 16th Feb 19
Plunging Inventories have Zinc Bulls Ready to Run - 15th Feb 19
Gold Stocks Mega Mergers Are Bad for Shareholders - 15th Feb 19
Retail Sales Crash! It’s 2008 All Over Again for Stock Market and Economy! - 15th Feb 19
Is Gold Market 2019 Like 2016? - 15th Feb 19
Virgin Media's Increasingly Unreliable Broadband Service - 15th Feb 19
2019 Starting to Shine But is it a Long Con for Stock Investors? - 15th Feb 19
Gold is on the Verge of a Bull-run and Here's Why - 15th Feb 19
Will Stock Market 2019 be like 1999? - 14th Feb 19
3 Charts That Scream “Don’t Buy Stocks” - 14th Feb 19
Capitalism Isn’t Bad, It’s Just Broken - 14th Feb 19
How To Find High-Yield Dividend Stocks That Are Safe - 14th Feb 19
Strategy Session - How This Stocks Bear Market Fits in With Markets of the Past - 14th Feb 19
Marijuana Stocks Ready for Another Massive Rally? - 14th Feb 19
Wage Day Advance And Why There is No Shame About It - 14th Feb 19
Will 2019 be the Year of the Big Breakout for Gold? - 13th Feb 19
Earth Overshoot Day Illustrates We are the Lemmings - 13th Feb 19
A Stock Market Rally With No Pullbacks. What’s Next for Stocks - 13th Feb 19
Where Is Gold’s Rally in Response to USD Weakness? - 13th Feb 19

Market Oracle FREE Newsletter

Category: BioTech

The analysis published under this category are as follows.

Companies

Friday, November 23, 2018

DNA Breakthrough: Scientists Repair Genes in Human Embryos / Companies / BioTech

By: Andrew_Cioffi

The medical field is set to change tremendously owing to a recent breakthrough by medical researchers. A team of researchers recently managed to use gene-editing tools to remove mutations in embryos which develop into human diseases. The team that comprised of the Oregon Health and Science University and other researchers were able to make breakthrough discoveries. The particular disease, hypertrophic cardiomyopathy, is passed down genetically and is a cause of many deaths especially among young athletes. It is not clear yet as to when the technology will be applied in the real world.

Read full article... Read full article...

 


Companies

Thursday, May 03, 2018

4 Biotech Stock Movers to Watch / Companies / BioTech

By: Harry_Boxer

Biotechs continue to dominate our list of top charts to watch.

CASI Pharmaceuticals Inc. (CASI) rose 48 cents, or 7.2%, to $7.14 on 773,700 shares Tuesday. The move came on no news, although the stock soared in early April on news that China's Food and Drug Administration (CFDA) would convene a panel to discuss its cancer therapy, Evomela. The stock has been flagging since that move, but may be positioning to break out, with the next target at $10.

Read full article... Read full article...

 


Companies

Monday, September 11, 2017

Could This Be The Biggest Biotech Breakthrough Of The Year? / Companies / BioTech

By: OilPrice_Com

Someone dies of a stroke every 4 minutes in the United States. Globally, 15 million people suffer a stroke every year. It’s debilitating physically and financially—but one little-known company has developed a medical device that hopes to challenge that deadly statistic.

It’s been quietly developing this new technology for 10 years. Now it’s released updated preliminary clinical trial results, and signed a manufacturing deal which could make a significant impact in the medical device industry.

After a decade of painstaking development, we’re now nearing the end of the long road to validation, and for investors who understand this industry, this could be the critical juncture.

Read full article... Read full article...

 


Companies

Wednesday, July 19, 2017

Biotech with Alzheimer's Focus Makes Progress on Several Fronts / Companies / BioTech

By: TLSReport

In its corporate update for Q2/17, a Canada-based biotech targeting neurological disorders including Alzheimer's disease informed investors of advancements in several programs, including designation of a second validated lead compound in development.

Among ProMIS Neurosciences Inc.'s (PMN:TSE) "key accomplishments" in the quarter, the company noted it expanded its potentially "best in class amyloid-beta (Aβ) portfolio for Alzheimer's disease," according to a July 10 news release. In its oral presentation, the company stressed its emphasis on the "best in class" goal, noting that even though Biogen Inc.'s (BIIB:NASDAQ) aducanumab will be "first in class" and is progressing well in development, the ProMIS compound could be more selective and possess greater patient benefits.

Read full article... Read full article...

 


Companies

Sunday, April 23, 2017

After The Crash - Digital And Regenerative Medicine, Live for Ever! / Companies / BioTech

By: John_Rubino

For most people, the doctor visit hasn’t changed in decades. Same physical waiting rooms, same paper forms to fill out, same slow, expensive tests and marginally-effective, maximally-invasive treatments. But that’s about to change, as a wave of new technologies drag medicine into the 21st century. Among the most interesting:

Read full article... Read full article...

 


Companies

Tuesday, April 18, 2017

The Smart Money Is Piling Into Regenerative Medicine / Companies / BioTech

By: John_Mauldin

BY PATRICK COX : The Congressional Budget Office released its long-term budget outlook. This report should have sparked a national discussion about societal aging, but big media largely ignored it.

Fortunately, there are signs that smart investors are hedging this failure by investing in regenerative medicine (RM).

Read full article... Read full article...

 


Companies

Wednesday, April 05, 2017

British Billionaire Jim Mellon Says Biotech Is the Best Investment Now / Companies / BioTech

By: John_Mauldin

BY PATRICK COX : We are in the midst of an unprecedented change. Life spans have nearly doubled since the beginning of the 20th century. In addition, recent advances in computer technology have had a huge impact on biological sciences, which means this trend will accelerate.

Still, most people think that the process of aging will go on pretty much as it is now. They’re wrong.

Read full article... Read full article...

 


Companies

Monday, March 13, 2017

... / Companies / BioTech

By: OilPrice_Com

...

 


Companies

Tuesday, February 28, 2017

Major Funds Betting On Trump BioTech Sector / Companies / BioTech

By: TLSReport

Donald Trump's presidency is a real nitro boost for the future of the biotech sector in the U.S., says Tom Beck, editor of Portfolio Wealth Global.

Donald Trump's presidency is a massive boost to all industries, and is a real nitro boost for the future of the biotech sector in the U.S.

With 80 million baby-boomers looking to stay young and vital for a very long time, you should be making your move, and market-beating returns will be occurring from the large-cap stocks and in the small-cap sector even more so.

Read full article... Read full article...

 


Companies

Tuesday, January 24, 2017

The Last Time This Happened, Biotech Stocks Plunged by 50% / Companies / BioTech

By: John_Mauldin

BY PATRICK WATSON : “They’re getting away with murder,” said Donald Trump at last week’s epic news conference.

No, he didn’t mean Russian hackers. He was talking about red-blooded American drug companies.

Trump went on: “Pharma has a lot of lobbyists and a lot of power, and there is very little bidding. We’re the largest buyer of drugs in the world, and yet we don’t bid properly, and we’re going to save billions of dollars.”

Read full article... Read full article...

 


Companies

Wednesday, January 18, 2017

Biotech Breakthrough Could Create A $11.4 Trillion Opportunity / Companies / BioTech

By: OilPrice_Com

....

 


Companies

Saturday, December 03, 2016

Can Biotech's Trump Bump Last? / Companies / BioTech

By: TLSReport

In the weeks since Donald Trump's presidential election victory, the stock markets have ridden a wave into positive—and in the case of the Dow, record-breaking—territory. The so-called Trump Bump also sent biotech indices, flaccid for much of the year, up as much as 15%. With the election now nearly a month old, and hot-button issues such as drug pricing still in the press, industry watchers have begun to weigh in on what might happen in the biotech and pharma markets when Trump takes office.

Read full article... Read full article...

 


Economics

Monday, November 21, 2016

Trump Can Fix US Economy by Embracing Biotech / Economics / BioTech

By: John_Mauldin

BY PATRICK COX : The presidential campaign made one fact very clear. Most of the media and public aren't focused on economic growth.

Growth powers and funds everything else. Just take a look at the enormous federal deficit and you’ll see that economic health keeps taking a back seat to short-term goals.

Yes, John Maynard Keynes made a case for using debt to stimulate the economy. But he never said anything about permanent deficits. And that is our current practice. The result is that taxpayers’ options will be curtailed in the future.

Read full article... Read full article...

 


Companies

Thursday, November 03, 2016

The Rise in Infectious Diseases Means Opportunity for Biotech Investors / Companies / BioTech

By: John_Mauldin

BY PATRICK COX : The CDC has expanded its count of Miami neighborhoods with verified local transmission of the Zika virus. As a result, pregnant women are taking precautions. Some have left the area. Others are donning hazmat suits.

At least one case of locally acquired Zika has been confirmed on Florida’s Gulf Coast where I live, and there are probably more. This is because most people don’t know that they’ve been infected and are carriers.

Read full article... Read full article...

 


Companies

Wednesday, September 21, 2016

Imagin, a Better Way to Detect Bladder Cancer / Companies / BioTech

By: TLSReport

Bob Moriarty profiles Imagin Medical, a company that has developed a new way of detecting bladder cancer through endoscopes.

The most common cancers in the U.S. are hardly the most expensive to treat. More Americans come down with breast cancer and lung cancer than any other types of cancer. The worst cancer from a perspective of expense turns out to be bladder cancer that is only the 6th most prevalent form of disease.

Read full article... Read full article...

 


Stock-Markets

Thursday, September 15, 2016

Great Day for Biotech Stocks / Stock-Markets / BioTech

By: Harry_Boxer

The stock market indices rebounded smartly in the morning, but got up to overhead resistance, particularly on the Nasdaq 100, which failed several times trying to get through 4770. At that point, the S&P 500 was trailing badly. They then went into an afternoon decline, and orderly retraced channel, 5-wave decline on the S&P 500, and then dropped right back to the 2120 level it reached twice in three days. This was the third test. That was successful. It bounced a few points off that level. It was not exactly a rip-roaring rally, but, nevertheless, support held for now, with the S&P 500 having a triple bottom, and the Nasdaq 100 having a right-handed, extended V-pattern, or rising wedge. No question with overhead resistance at 4770, or thereabouts on the Nasdaq 100, as well as for starters 2140-5 zone on the S&P 500 is going to be critical going forward.

Read full article... Read full article...

 


Companies

Wednesday, June 08, 2016

Investment in Cell and Gene Therapies Ramps Up / Companies / BioTech

By: TLSReport

After decades of disappointment, cell therapies and gene therapies are finally seeing light at the end of the tunnel. Investors, investigators, clinicians, and patients with serious unmet needs are watching pivotal trials move into the home stretch. Yes. . .pivotal data are actually on the way.

Though the roadblocks that have held back development of cell and gene therapies since the mid-1990s have been expensive in terms of a lingering hangover with depressed valuations, investors are now looking at achievement in terms of meaningful endpoints.

Read full article... Read full article...

 


Companies

Tuesday, June 07, 2016

Detecting Cancer With White and Blue Light / Companies / BioTech

By: Richard_Mills

Endoscopy is often used in the prevention, early detection, diagnosis, staging, and treatment of cancer.

X-rays and CT scans can show physical changes within the body and give information about the size, shape, and location of the changes. Endoscopes show details like color and surface texture allowing doctors to see exactly what’s going on.

If you go to a doctor exhibiting certain symptoms, endoscopy could be used to find the cause:

Read full article... Read full article...

 


Companies

Thursday, April 07, 2016

IBB (Biotech ETF) Baby Bull Market / Companies / BioTech

By: Gary_Savage

Here we go again. Remember when I warned traders not to short the baby bull in miners and exhorted them to not lose their position because surprises would come to the upside? Needless to say, many ignored that advice and they cost themselves dearly.

Now we have a second baby bull just getting started in Biotech. It still has a long ways to go. Yet I’m seeing some traders making the same mistakes again.

Read full article... Read full article...

 


Companies

Thursday, March 10, 2016

Seven Small-Cap Biotech Stocks on the Upswing 2016 / Companies / BioTech

By: TLSReport

Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China. The Life Sciences Report's 2016 Small-Cap Biotech Watchlist was not immune to that movement, heading into negative territory almost from the moment the selected companies were introduced. But as the market has shown signs of rebounding, so too has the Watchlist.

Read full article... Read full article...

 


Page << | 1 | 2 | 3 | 4 | >>